[HTML][HTML] Comparative study of subcutaneous and orthotopic mouse models of prostate cancer: vascular perfusion, vasculature density, hypoxic burden and BB2r …
The gastrin-releasing peptide receptor (BB2r) is overexpressed in a variety of cancers
including prostate cancer. As a consequence, the development of BB2r-targeted …
including prostate cancer. As a consequence, the development of BB2r-targeted …
[HTML][HTML] Gastrin-releasing peptide receptor-based targeting using bombesin analogues is superior to metabolism-based targeting using choline for in vivo imaging of …
RPJ Schroeder, WM Van Weerden… - European journal of …, 2011 - Springer
Purpose Prostate cancer (PC) is a major health problem. Overexpression of the gastrin-
releasing peptide receptor (GRPR) in PC, but not in the hyperplastic prostate, provides a …
releasing peptide receptor (GRPR) in PC, but not in the hyperplastic prostate, provides a …
Preclinical pharmacokinetic, biodistribution, imaging and therapeutic efficacy of 177Lu-Labeled glycated bombesin analogue for gastrin-releasing peptide receptor …
JC Lim, EH Cho, JJ Kim, SM Choi, SY Lee… - Nuclear Medicine and …, 2015 - Elsevier
The gastrin-releasing peptide receptor (GRPR) has been shown to be overexpressed in
many human tumors, including prostate, colon, gastric, breast, pancreatic, and small cell …
many human tumors, including prostate, colon, gastric, breast, pancreatic, and small cell …
Evaluation of Combined 177Lu-DOTA-8-AOC-BBN (7-14)NH2 GRP Receptor-Targeted Radiotherapy and Chemotherapy in PC-3 Human Prostate Tumor Cell …
The focus of this study was to evaluate the therapeutic benefit of combined gastrin-releasing
peptide (GRP) receptor-targeted radiotherapy (TRT) with chemotherapy, using the PC-3 …
peptide (GRP) receptor-targeted radiotherapy (TRT) with chemotherapy, using the PC-3 …
A Radiotracer for molecular imaging and therapy of gastrin-releasing peptide receptor–positive prostate cancer
The gastrin-releasing peptide receptor (GRPR) is overexpressed in many solid
malignancies, particularly in prostate and breast cancers, among others. We synthesized …
malignancies, particularly in prostate and breast cancers, among others. We synthesized …
18F-labeled bombesin analog for specific and effective targeting of prostate tumors expressing gastrin-releasing peptide receptors
M Honer, L Mu, T Stellfeld, K Graham… - Journal of Nuclear …, 2011 - Soc Nuclear Med
Bombesin is a peptide exhibiting high affinity for the gastrin-releasing peptide receptor
(GRPr), which is highly overexpressed on prostate cancer cells. In the present study, we …
(GRPr), which is highly overexpressed on prostate cancer cells. In the present study, we …
Near‐infrared fluorescence imaging of gastrin releasing peptide receptor targeting in prostate cancer lymph node metastases
QY Cai, P Yu, C Besch‐Williford, CJ Smith… - The …, 2013 - Wiley Online Library
BACKGROUND Development of high affinity and specificity molecular imaging probes that
increase accuracy for early detection of lymph node (LN) metastases is important for …
increase accuracy for early detection of lymph node (LN) metastases is important for …
18F-labeled bombesin analogs for targeting GRP receptor-expressing prostate cancer
The gastrin-releasing peptide receptor (GRPR) is found to be overexpressed in a variety of
human tumors. The aim of this study was to develop 18F-labeled bombesin analogs for PET …
human tumors. The aim of this study was to develop 18F-labeled bombesin analogs for PET …
Dual-modality imaging of prostate cancer with a fluorescent and radiogallium-labeled gastrin-releasing peptide receptor antagonist
H Zhang, P Desai, Y Koike, J Houghton… - Journal of Nuclear …, 2017 - Soc Nuclear Med
Gastrin-releasing peptide (GRP) receptors (GRPr) are frequently overexpressed in human
prostate cancer, and radiolabeled GRPr affinity ligands have shown promise for in vivo …
prostate cancer, and radiolabeled GRPr affinity ligands have shown promise for in vivo …
microPET and autoradiographic imaging of GRP receptor expression with 64Cu-DOTA-[Lys3] bombesin in human prostate adenocarcinoma xenografts
X Chen, R Park, Y Hou, M Tohme… - Journal of Nuclear …, 2004 - Soc Nuclear Med
Overexpression of gastrin-releasing peptide (GRP) receptor (GRPR) in both androgen-
dependent (AD) and androgen-independent (AI) human neoplastic prostate tissues provides …
dependent (AD) and androgen-independent (AI) human neoplastic prostate tissues provides …
相关搜索
- mouse models of prostate cancer
- hypoxic burden prostate cancer
- vascular perfusion prostate cancer
- peptide receptor prostate cancer
- therapeutic efficacy prostate tumor
- human prostate cancer xenografts
- positive prostate cancer
- prostate cancer imaging
- human prostate tumor cell
- bombesin analogue prostate tumor
- preclinical pharmacokinetic prostate tumor
- vascular perfusion hypoxic burden
- prostate tumors peptide receptors
- bombesin analog peptide receptors
- peptide receptor fluorescence imaging
- peptide receptor molecular imaging